Interaction of ambient air pollution with asthma medication on exhaled nitric oxide among asthmatics

19Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

The interaction between ambient air pollution and asthma medication remains unclear. The authors compared airway inflammation response to air pollution among asthmatics. Increases of 10 ppb of nitrogen dioxide (NO2) and of 10 μg/m3 of particulate matter < 10 micron in diameter (PM10) daily concentrations were associated with an increase in exhaled nitric oxide (eNO) of 0.13 ppb (95% confidence interval = 0.06, 0.19) and of 0.07 ppb (95% confidence interval = 0.02, 0.12), respectively, in models adjusted for important covariates. The results show that the medication could not counteract airway inflammation effects of air pollution. Specifically, the patients on triamcinolone decreased the sensitivity to PM10 but increased the sensitivity to O2. The patients on salmeterol were more vulnerable to both NO2 and PM10. This study indicates that the current pollution levels may still enhance airway inflammation among patients with persistent asthma even when they are on asthma medications. © 2009 Heldref Publications.

Cite

CITATION STYLE

APA

Qian, Z., Lin, H. M., Chinchilli, V. M., Lehman, E. B., Duan, Y., Craig, T. J., … Bascom, R. (2009). Interaction of ambient air pollution with asthma medication on exhaled nitric oxide among asthmatics. Archives of Environmental and Occupational Health, 64(3), 168–176. https://doi.org/10.1080/19338240903240616

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free